Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.


Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?


Arrhythmia & Electrophysiology Review 2015;4(3):163–8

The Use of Gene Therapy for Ablation of Atrial Fibrillation


Arrhythmia & Electrophysiology Review 2014;3(3):139–44

Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions


Arrhythmia & Electrophysiology Review 2014;3(3):194–200

Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation


Arrhythmia & Electrophysiology Review 2015;4(1):44-6